Catalyst Private Wealth’s CVS Health CVS Stock Holding History

Catalyst Private Wealth’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-138	Closed	-$8K	–	100
2020 Q3	$8K	Buy	+138	New	+$8.59K	0.01%	220

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Catalyst Private Wealth's CVS Position: Q4 2020 in Review

Catalyst Private Wealth sold out of CVS Health (CVS) in Q4 2020, closing a stake of 138 shares — an estimated $8K sold.

Catalyst Private Wealth first reported a position in CVS in Q3 2020 and held it in 1 quarter. The position peaked at $8K in Q3 2020. 1,972 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

Catalyst Private Wealth reported no remaining CVS Health position as of Q4 2020 after selling out during the quarter.
Catalyst Private Wealth sold 138 CVS Health shares in Q4 2020, an estimated $8K.
Catalyst Private Wealth first reported a position in CVS Health in Q3 2020 and held it in 1 quarter.
Catalyst Private Wealth's CVS Health position peaked at $8K in Q3 2020.
1,972 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Catalyst Private Wealth's 13F filing for Q4 2020, filed 5 Mar 2021.